HomeREVB • NASDAQ
add
Revelation Biosciences Inc
Previous close
$3.08
Day range
$3.00 - $3.30
Year range
$2.36 - $60.80
Market cap
2.94M USD
Avg Volume
111.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.09M | 10.14% |
Net income | -2.05M | 23.51% |
Net profit margin | — | — |
Earnings per share | -2.11 | 94.64% |
EBITDA | -2.09M | -10.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.70M | -74.54% |
Total assets | 3.97M | -72.99% |
Total liabilities | 1.09M | -79.16% |
Total equity | 2.88M | — |
Shares outstanding | 971.31K | — |
Price to book | 1.04 | — |
Return on assets | -98.89% | — |
Return on capital | -138.03% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.05M | 23.51% |
Cash from operations | -2.79M | 1.53% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -2.79M | -209.15% |
Free cash flow | -2.28M | -60.52% |
About
Founded
2019
Website
Employees
8
